Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.66 USD -4.05% Market Closed
Market Cap: $7.4m

Profitability Summary

Interpace Biosciences Inc's profitability score is 63/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

63/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

63/100
Profitability
Score
63/100
Profitability
Score

Margins

Earnings Waterfall
Interpace Biosciences Inc

Margins Comparison
Interpace Biosciences Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Interpace Biosciences Inc
OTC:IDXG
7.3m USD
Loading...
Loading...
Loading...
US
CVS Health Corp
NYSE:CVS
89.1B USD
Loading...
Loading...
Loading...
US
Cigna Group
XMUN:CGN
68B EUR
Loading...
Loading...
Loading...
US
Cigna Corp
NYSE:CI
69B USD
Loading...
Loading...
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.8B EUR
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
22.5B EUR
Loading...
Loading...
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD
Loading...
Loading...
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21.5B USD
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR
Loading...
Loading...
Loading...
US
Guardant Health Inc
NASDAQ:GH
11.1B USD
Loading...
Loading...
Loading...
US
DaVita Inc
NYSE:DVA
10.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Interpace Biosciences Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Interpace Biosciences Inc
OTC:IDXG
7.3m USD
Loading...
Loading...
Loading...
Loading...
US
CVS Health Corp
NYSE:CVS
89.1B USD
Loading...
Loading...
Loading...
Loading...
US
Cigna Group
XMUN:CGN
68B EUR
Loading...
Loading...
Loading...
Loading...
US
Cigna Corp
NYSE:CI
69B USD
Loading...
Loading...
Loading...
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.8B EUR
Loading...
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
22.5B EUR
Loading...
Loading...
Loading...
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD
Loading...
Loading...
Loading...
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21.5B USD
Loading...
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR
Loading...
Loading...
Loading...
Loading...
US
Guardant Health Inc
NASDAQ:GH
11.1B USD
Loading...
Loading...
Loading...
Loading...
US
DaVita Inc
NYSE:DVA
10.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Interpace Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett